Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 4 min ago
Peer-reviewedCC BYHemaSphere

Immune and cellular determinants of response to HMA‐venetoclax regimens in acute myeloid leukemia

16 more authors
4 affiliations
  1. 1University of Milan
  2. 2Hematology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
  3. 3IRCCS Humanitas Research Hospital
  4. 4Clinical Pathology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico

Related

  1. Genomic and clinical determinants of response to Azacitidine plus venetoclax in acute myeloid leukemia: Results from the HM-SCREEN-Japan 02 study
    Tomoaki Ueda, Kentaro Fukushima, Sunggi Chi +12
    PLOS OnePeer-reviewedCC BY 4.0Full textOncologyPhysiologyPLOS
  2. Combining the Telomerase Inhibitor Imetelstat with the BCL-2 Inhibitor Venetoclax Enhances Apoptosis and Improves Survival in Acute Myeloid Leukemia Cellular and Animal Models
    Fei Huang, Joshua J. Rusbuldt, Leopoldo Luistro +2
    Journal of clinical medicinePeer-reviewedCC BYFull textGeneral medicineEurope PMC
  3. COMPARISON OF INTENSIVE CHEMOTHERAPY VERSUS VENETOCLAX-BASED REGIMENS IN ADULTS AGED 50-75 YEARS WITH ACUTE MYELOID LEUKEMIA: A PROPENSITY SCORE-MATCHED ANALYSIS
    Luiza Lapolla PERRUSO, Wellington Fernandes SILVA, Abel COSTA +12
    Hematology, Transfusion and Cell TherapyPeer-reviewedCC BYFull textEndocrinology & metabolismDOAJ
  4. Response to Venetoclax and Azacitidine in Induction-Refractory Adult Acute Myeloid Leukemia with UBTF Tandem Duplication and Associated Aberrant Splicing: A Case Report
    Seigi Oshima, Kazuhisa Chonabayashi, Takashi Sakamoto +11
    Internal MedicinePeer-reviewedCC BY-NC-NDFull textGeneral medicineJ-STAGE
  5. Effects of azacitidine combined with venetoclax on inflammatory markers and overall response rate in elderly patients with newly diagnosed acute myeloid leukemia
    Hui-Fang Liu, Cheng Lian, Xian-Guang Zhu
    BMC GeriatricsPeer-reviewedCC BYFull textGeneral medicineDOAJ
BibTeX
@article{marchetti2026immune,
  title = {{Immune and cellular determinants of response to HMA‐venetoclax regimens in acute myeloid leukemia}},
  author = {Alfredo Marchetti and Francesca Lazzaroni and Matteo Claudio Da Via' and Marta Lionetti and Giulia Maggioni and Alessia Campagna and Denise Ventura and Giorgio A. Croci and Alessio Marella and Akihiro Maeda and Antonio Matera and Emanuele Calvi and Margherita Scopetti and Filippo Viviani and Nicolò Rampi and Davide Bonometti and Elena Benzoni and Manuela Zappa and Sonia Fabris and Marzia Barbieri and Stefania Pioggia and Claudia Leoni and Antony Ricchiuti and Matteo G. D. Porta and Mariarita Sciumè and Francesco Passamonti and Nicola S. Fracchiolla and Niccolò Bolli},
  journal = {HemaSphere},
  year = {2026},
  month = oct,
  url = {https://europepmc.org/article/PMC/PMC13660835},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Immune and cellular determinants of response to HMA‐venetoclax regimens in acute myeloid leukemia
AU  - Alfredo Marchetti
AU  - Francesca Lazzaroni
AU  - Matteo Claudio Da Via'
AU  - Marta Lionetti
AU  - Giulia Maggioni
AU  - Alessia Campagna
AU  - Denise Ventura
AU  - Giorgio A. Croci
AU  - Alessio Marella
AU  - Akihiro Maeda
AU  - Antonio Matera
AU  - Emanuele Calvi
AU  - Margherita Scopetti
AU  - Filippo Viviani
AU  - Nicolò Rampi
AU  - Davide Bonometti
AU  - Elena Benzoni
AU  - Manuela Zappa
AU  - Sonia Fabris
AU  - Marzia Barbieri
AU  - Stefania Pioggia
AU  - Claudia Leoni
AU  - Antony Ricchiuti
AU  - Matteo G. D. Porta
AU  - Mariarita Sciumè
AU  - Francesco Passamonti
AU  - Nicola S. Fracchiolla
AU  - Niccolò Bolli
PY  - 2026
DA  - 2026/10/01
JO  - HemaSphere
UR  - https://europepmc.org/article/PMC/PMC13660835
SN  - 2572-9241
ER  -